A man walks near the Municipal Corporation Building, left, and the Chhatrapati Shivaji Maharaj Terminus (CSMT) during a lockdown imposed due to the coronavirus in Mumbai, India. (Photographer: Dhiraj Singh/Bloomberg)
A man walks near the Municipal Corporation Building, left, and the Chhatrapati Shivaji Maharaj Terminus (CSMT) during a lockdown imposed due to the coronavirus in Mumbai, India. (Photographer: Dhiraj Singh/Bloomberg)

Coronavirus India Updates: India Reports Over 2 Lakh Daily Covid-19 Cases For A Third Day In A Row

India recorded another day of record-high new Covid-19 infections as the country’s already crippled healthcare infrastructure grapples with a shortage of hospital beds, critical drugs and oxygen supplies.

More than 2.34 lakh people tested positive for the coronavirus in a matter of 24 hours, according to the Health Ministry's update as of 8:00 a.m. on April 17. Active caseload rose to 16.7 lakh—a record high.

India has reported more than 2 lakh daily cases for three days in a row now.

India recorded another day of record-high new Covid-19 infections as the country’s already crippled healthcare infrastructure grapples with a shortage of hospital beds, critical drugs and oxygen supplies.

More than 2.34 lakh people tested positive for the coronavirus in a matter of 24 hours, according to the Health Ministry's update as of 8:00 a.m. on April 17. Active caseload rose to 16.7 lakh—a record high.

India has reported more than 2 lakh daily cases for three days in a row now.

Authorities have reported a spike in daily fatalities related to Covid-19 to the levels last seen in September 2020. More than 1,000 people succumbed to the illness for the fourth consecutive day.

Key Figures

  • Total number of confirmed cases: 1,45,26,609
  • Active cases: 16,79,740
  • Total cured/discharged/migrated: 1,26,71,220
  • Total deaths: 1,75,649
  • New infections in 24 hours: 2,34,692
  • Recoveries in a day: 1,23,354
  • Deaths in a single day: 1,341
  • Total vaccination shots given: 11,99,37,641

Also Read: India Has a Double Mutant Virus Variant. Should We Be Worried?

Meanwhile, with states flagging off a shortage in vaccine supply, the government announced grants to boost the output of indigenously developed Covaxin. The Centre will offer up to Rs 65 crore to Biotech’s new facility in Bengaluru which is being repurposed to increase production. The government expects the production of Covaxin to reach 10 crore doses per month by September 2021.

The country recently allowed Russia’s Sputnik V to be administered in India in hopes of easing the shortfall. It is also inviting Pfizer, Moderna, Johnson & Johnson and others to seek emergency use approval of their vaccines as early as possible, VK Paul, who heads a panel advising Prime Minister Narendra Modi on the country’s inoculation efforts, said at a press briefing on April 13.

Global Covid-19 Deaths Approach 3 Million

Global fatalities from Covid-19 are nearing 3 million. The relentless pace of death continues unabated despite vaccination efforts and is increasingly borne by the world’s poorest places.

Moderna Inc. said it will deliver fewer vaccines than planned to the U.K., Canada and other countries this quarter due to a shortfall in doses in its European supply chain. Ontario unveiled its strictest measures yet to restrict the movement of people, setting up checkpoints with neighbouring provinces to control a third viral wave in Canada.

The U.S. has administered 200 million doses of the Covid-19 vaccine as the roll out picks up pace. New York City Mayor Bill de Blasio is sticking to his call to start bringing city workers back to the office on May 3.

Also Read: Covid Claims 3 Million Lives as Burden Shifts to Poorer Nations

Catch all the global Covid-19 updates here

This Article is for
“BQ Blue Exclusive Users”
Subscription starts @ ₹48/week
SUBSCRIPTION BENEFITS
Exclusive Stories
Research Reports
Webinars & Events
BQ Journalism
Exclusive Newsletters
Minimal Ad Experience
Sign Up to read
this article for
You're almost there, what are you waiting for?
SUBSCRIPTION BENEFITS
Exclusive Stories
Research Reports
Webinars & Events
BQ Journalism
Exclusive Newsletters
Minimal Ad Experience
You have reached your
FREE stories limit
Subscription starts @ ₹48/week
SUBSCRIPTION BENEFITS
Exclusive Stories
Research Reports
Webinars & Events
BQ Journalism
Exclusive Newsletters
Minimal Ad Experience
Click here to subscribe to WhatsApp updates from BloombergQuint
Stay Updated With Coronavirus Outbreak News On BloombergQuint